You just read:

FibroStatin Announces Breakthrough in the Fight Against Drug-Resistant Cancer and Fibrosis. Novel Treatment Inhibits the Epithelial-Mesenchymal Transition (EMT), a Key Underlying Pathology Contributing to These Diseases.

News provided by

FibroStatin

Aug 03, 2016, 08:40 ET